RELATED PARTY TRANSACTIONS (Details) (USD $)	1 Months Ended	12 Months Ended				3 Months Ended		12 Months Ended										1 Months Ended	12 Months Ended	1 Months Ended		1 Months Ended	12 Months Ended			1 Months Ended	12 Months Ended				1 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2013 Shareholders non authorization rate [Member]	Jun. 30, 2013 Convertible Subordinated Debt [Member]	Dec. 31, 2013 Convertible Subordinated Debt [Member]	Dec. 31, 2013 Convertible Subordinated Debt [Member] First Issuance 30.00 per share [Member] January 2012 [Member]		Dec. 31, 2013 Convertible Subordinated Debt [Member] Second Issuance at 20.00 per share [Member] January 2012 [Member]		Dec. 31, 2013 Convertible Subordinated Debt [Member] Second Issuance at 20.00 per share [Member] May 2012 [Member]		Dec. 31, 2013 Convertible Subordinated Debt [Member] Third issuance 14.00 per share [Member] July 2012 [Member]		Dec. 31, 2013 Convertible Subordinated Debt [Member] Third issuance 14.00 per share [Member] August 2012 [Member]		Jan. 31, 2012 Director - Baruch Halpern [Member]	Dec. 31, 2013 Director - Baruch Halpern [Member]	Jan. 31, 2012 Director - Baruch Halpern [Member] Convertible Subordinated Debt [Member]	Dec. 31, 2011 Director - Baruch Halpern [Member] Convertible Subordinated Debt [Member]	Jan. 31, 2012 Director - Mr. Hoogenkamp [Member]	Dec. 31, 2013 Director - Mr. Hoogenkamp [Member]	Dec. 31, 2012 Director - Mr. Hoogenkamp [Member]	Apr. 30, 2012 Director - Mr. Hoogenkamp [Member]	Jan. 31, 2012 Other Officers and Directors [Member]	Dec. 31, 2013 Other Officers and Directors [Member] Note	Dec. 31, 2012 Other Officers and Directors [Member]	Dec. 31, 2013 HC and Halpern Entities [Member]	Dec. 31, 2012 HC and Halpern Entities [Member]	Apr. 30, 2013 W. John Short, CEO and director [Member]	Jan. 31, 2012 W. John Short, CEO and director [Member]	Dec. 31, 2013 Minimum [Member] Director - Baruch Halpern [Member]	Dec. 31, 2013 Maximum [Member] Director - Baruch Halpern [Member]
Related Party Transaction [Line Items]
Obligated to pay success fees (in hundredths)																																	2.50%	5.00%
Additional consideration paid on certain transactions (in hundredths)																																	2.50%	5.00%
Summary of transactional warrants listed below under terms of financial advisor agreement with HC [Abstract]
Date of Warrants								Jan. 31, 2012		Jan. 31, 2012		May 31, 2012		Jul. 31, 2012		Aug. 31, 2012
Number of Shares Under Warrants (in shares)	8,709	8,709						1,250		5,563		63		711		268
Exercise Price of Warrant								Exercisable immediately at $30.00 per share	[1],[2]	Exercisable immediately at $20.00 per share	[1],[2]	Exercisable immediately at $20.00 per share	[1],[2]	Exercisable immediately at $14.00 per share	[2]	Exercisable immediately at $14.00 per share	[2]
Share to be issued for cancelled warrants upon Shareholder authorization.	75,377	75,377
Fair value at time of exchange	$ 300,000	$ 300,000																	$ 2,900,000
Stated annual interest rate (in hundredths)	5.00%	5.00%			10.00%
Exercise price per warrant (in dollars per share)								$ 30.00		$ 20.00		$ 20.00		$ 14.00		$ 14.00
Expiration Date of Warrant								Jan. 31, 2017		Jan. 31, 2017		May 31, 2017		Jul. 31, 2017		Aug. 31, 2017
Notice period of warrant conversion		61 days
Minimum percentages of common stock considered as beneficial ownership interest (in hundredths)		4.99%
Exercise price of warrants (in dollars per share)	$ 6.55	$ 6.55					$ 14.00
Summary of other transactions and balances with HC and Halpern Entities [Abstract]
Success fees earned by HC under financial advisor agreement payable in cash																													0	164,000
Proceeds received from Mr. Halpern and Halpern Entities upon issuance of convertible debt and related warrants																													306,000	213,000
Interest earned by Halpern entities on convertible debt																													288,000	302,000
Payments to HC relevant to HC's class 6 general unsecured creditor claim																													0	256,000
Gain on extinguishment of debt						300,000													400,000
Subordinated convertible notes owned				100,000															2,600,000
Warrants canceled during the period																			185,714
Accounts payable or accrued expenses																													100,000	100,000
Warrants issued (in shares)																		25,833									234
Weighted average exercise price per warrant (in dollars per share)																		$ 20.00	$ 24.00	$ 16.00
Warrants granted in period, fair value																		100,000
Number of Securities Called by Warrants (in shares)	1,714,286	1,714,286																		178,572	125,000
Common stock issued for vendor services, (in shares)																						5,000
Consulting service fees																							100,000	100,000
Options vested (in shares)																									5,000
Vesting Period																							Vest in twelve equal monthly installments
Proceeds from issuance of subordinated long-term debt																										100,000					25,000	50,000
Interest paid maximum		$ 2,537,000	$ 1,651,000																								$ 1,000,000	$ 1,000,000
Number of subordinated convertible notes																											3
Issue of shares of common stock (in shares)	1,714,286																		634,679								82

[1] In 2013, in connection with the Exchange, these warrants were cancelled in exchange for 75,377 shares of our common stock (with a fair value of $0.3 million at time of the Exchange), however the shares will not be issued until after shareholders vote to approve an increase in our authorized shares of common stock. If shareholders do not approve an increase to the authorized number of shares of common stock by July 1, 2014, the interest rate on the replacement notes will increase from 5% to 10%.

[2] As a result of the July 31, 2012, issuances of convertible debt and related warrants, the exercise prices on these transactional warrants were reduced under the full ratchet anti-dilution provisions included in the transactional warrants, to $14.00 per share and the number of underlying shares increased to equal the number of original underlying shares times the initial exercise price divided by $14.00 per share.